Revenue | ₹1.48Cr |
Net Profits | ₹0.31Cr |
Net Profit Margins | -20.95% |
Norris Medicines Ltd’s revenue jumped 100% since last year same period to ₹1.48Cr in the Q1 2025-2026. On a quarterly growth basis, Norris Medicines Ltd has generated -46.57% fall in its revenue since last 3-months.
Norris Medicines Ltd’s net profit jumped 16.22% since last year same period to ₹0.31Cr in the Q1 2025-2026. On a quarterly growth basis, Norris Medicines Ltd has generated -34.78% fall in its net profits since last 3-months.
Norris Medicines Ltd’s net profit margin jumped 58.11% since last year same period to -20.95% in the Q1 2025-2026. On a quarterly growth basis, Norris Medicines Ltd has generated -152.26% fall in its net profit margins since last 3-months.
The revenue for Norris Medicines Ltd in the Q1 results 2025 was ₹1.48Cr.
The net profit for Norris Medicines Ltd in the Q1 results 2025 was ₹0.31Cr.
The net profit margin for Norris Medicines Ltd in the Q1 results 2025 was -20.95%.
The revenue for Norris Medicines Ltd in the Q1 results 2024 was ₹0.74Cr.
The net profit for Norris Medicines Ltd in the Q1 results 2024 was ₹0.37Cr.
The net profit margin for Norris Medicines Ltd in the Q1 results 2024 was -50.00%.